Gaucher-kór: vizsgálatok itt: India
1 of 2 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in IndiaStudy to Evaluate the Efficacy and Safety of Nizubaglustat (AZ-3102) in Patients With Gaucher Disease Type 3 (GD3)
- Where
- Jaipur, New Delhi
- Életkor
- 4 év to 30 év
- People
- 20 worldwide
- Run by
- Azafaros B.V.
See details and how to joinNCT07715084